Navigation Links
A Best Manuscript Award Goes to the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai

New York, NY (PRWEB) November 17, 2013

The Editors of the American Heart Association’s (AHA) journal Circulation Research have awarded Icahn School of Medicine at Mount Sinai researchers a “Best Manuscript Award” for their investigations on repair and reversal of heart attack damage.

The winning manuscript, “Stem Cell Factor Gene Transfer Promotes Cardiac Repair After Myocardial Infarction via In Situ Recruitment and Expansion of c-kit+ Cells,” was published in the Nov. 9, 2012 issue.

The manuscript was one of only five research articles honored among the 204 articles published in the journal between July 2012 and June 2013. The award was presented on Nov. 17 to the Mount Sinai study’s lead author Elisa Yaniz-Galende, PhD, and senior-author Roger J. Hajjar, MD, during the AHA Scientific Sessions 2013 in Dallas, Texas.

Additional co-authors sharing this honor from Mount Sinai are Valentin Fuster, MD, PhD, Jiqiu Chen, MD, Elie Chemaly, MD, Lifan Liang, MD, Jean-Sebastien Hulot, MD, PhD, LaTronya McCollum, PhD, and Teresa Arias, PhD; and Krisztina M. Zsebo, PhD, from the Celladon Corporation.

Their team’s study manuscript was selected for its high standards of scientific exellence for novelty, impact, and methodology and because it represents some of the very best work published in Circulation Research. Also, the study was recognized as one of the 2012 top ten most read original articles.

“We are extremely honored to be applauded by the editors of Circulation Research for our innovative research findings and our collaborative research team’s hard work,” says senior author Dr. Roger Hajjar, Director of the Cardiovascular Research Center and the Arthur & Janet C. Ross Professor of Medicine at Icahn School of Medicine at Mount Sinai. “We sincerely thank the journal for this wonderful recognition, publishing our manuscript, and sharing our important advancement in cardiac regenerative medicine with the world.”

The award winning manuscript reported how to enhance cardiac repair and reverse injury after a heart attack. The study identified the critical role stem cell factor (SCF) molecules can play in cardiac repair and cardiac regeneration through recruitment and expansion of cardiac c-kit+ progenitor and stem cells. In their preclinical study, researchers showed the potential clinical benefits of using SCF adenoviral gene transfer shortly after heart attack to gain a regenerative repair response. Research results showed SCF overexpression can help increase recruitment of resident cardiac c-kit+ progenitor and stem cells to the damaged heart attack area and increase the presence of other cardiac cells known as cardiomyocytes. This potential therapy showed significant improvement in cardiac function, reduced heart damage, and minimized cardiac muscle cell death.

“It is always a true honor to collaborate with Dr. Hajjar on stellar research publications such as this winning manuscript. I congratulate him and the rest of our team at Mount Sinai Heart on a job well done,” says Dr. Fuster, co-author of the study, Director of Mount Sinai Heart and Physician-in-Chief at The Mount Sinai Hospital. Dr. Fuster is past President of the AHA and the next Editor-in-Chief of the Journal of the American College of Cardiology (JACC). “I am very proud of Dr. Hajjar for his strong leadership and contributions in the field of cardiovascular research and translational medicine.”

In 2012, Dr. Fuster was honored at the AHA Scientific Sessions with its Research Achievement Award for his significant and enduring contributions to cardiovascular medicine, achievements that have accelerated progress toward conquering disease and enriching the human condition worldwide.

In addition, on Nov. 19 at the AHA Scientific Sessions 2013 Dr. Hajjar will be named by the Officers of the AHA and the Council on Basic Cardiovascular Sciences as the recipient of the 2013 BCVS Distinguished Achievement Award. He is recognized as a Council member who has made major contributions to the affairs of a Scientific Council and for his substantial professional contributions to the field of cardiovascular research.

About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit
Find Mount Sinai on:
Twitter @mountsinainyc

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chicago Screening to Celebrate Down Syndrome Film’s Reception of National Award at 2013 Tash Conference with Governor of Illinois 12.12.2013
2. NHS Human Services Foundation to Host 10th Annual Leading the Way Awards Gala
3. Mount Sinais Arvin Dar, Ph.D., receives NIH New Innovator Award for drug development
4. 3 Prestigious Awards for Wisdom Natural Brands President
5. Company co-founded by UH researcher wins Nanomedicine Award
6. GRAFF®’s Ametis Shower System Honored With Architectural Products Magazine’s Prestigious Product Innovation Award
7. Halo Therapeutics Receives $500,000 MDA Award to Develop Drug for Duchenne Muscular Dystrophy
8. Vena Solutions is a Winner of Deloitte’s 2013 Companies-to-Watch Award
9. Patricia Leuchten of The Avoca Group Wins Bronze Stevie® Award in 2013 Stevie Awards for Women in Business
10. Top Accolades Awarded to Angry Citizen, Ecocat, Medesk and WESTUDY.IN At Challenge Cup Moscow
11. LAUFEN’s Revolutionary SaphirKeramik Ceramic Collection Honored With Prestigious Product Innovation Award
Post Your Comments:
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... Los Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... author explored the different restrictions and variables that determine which patients are or are ... are those patients that have a BMI over 40, are more than 100 pounds ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... AL (PRWEB) , ... November 24, 2015 , ... American ... announced today the opening of a holiday pop-up clinic located in Metro Atlanta’s North ... needs in a new and different way. The location is scheduled to operate through ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... meeting of shareholders held today, the Company,s shareholders voted ... the previously announced agreement and plan of merger (the ...
(Date:11/24/2015)... , Nov. 24, 2015  In the pharmaceutical ... in an effort to quickly uncover new insights, tactics ... --> --> However, organizations ... market research project and ensure that all rules and ... industry standards. Another major barrier to efficiently launching market ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: